Screener
Glaukos GKOS Business Segments
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| Revenue by Product | ||||||
| Corneal Health | $30.43M+47.8% | $21.31M+15.0% | $23.97M+12.2% | $23.29M+12.8% | $20.59M+3.9% | |
| Glaucoma | $155.18M+49.9% | $129.26M+46.7% | $119.15M+41.6% | $110.25M+45.0% | $103.53M+36.4% | |
| Revenue by Geography | ||||||
| Non Us | $38.87M+15.7% | $38.23M+21.0% | $35.12M+17.3% | $32.09M+20.4% | $33.6M+16.4% | |
| US | $146.74M+62.1% | $112.34M+49.7% | $108M+42.9% | $101.45M+44.9% | $90.52M+35.5% |
FAQ
- How does Glaukos break its business down?
- Glaukos (GKOS) reports revenue by product across 2 parts — Corneal Health and Glaucoma. Each is extracted from the segment footnotes and tracked over time.
- Where does Glaukos's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Glaukos's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
